Mevion Medical Systems

10/17/2025

Congratulations to our partners at Leo Cancer Care on this incredible recognition in Forbes! We are inspired by their vision, innovation, and dedication to advancing patient-centered cancer care. Their recognition in Forbes is a testament to their leadership in reshaping the future of oncology.

Pinch us… is that really our name in Forbes? 🌟
Read the coverage here:https://obi41.nl/2p9789k3

Huge congratulations to Stephen and Rock, our Co-Founders, for building a business that’s earned this recognition. Our story is one of humanity, resilience, and a little bit of boldness.

10/15/2025

Yesterday was a proud moment for Mevion as we joined Atlantic Health to celebrate the groundbreaking of the MEVION S250-FIT Proton Therapy System at Morristown Medical Center.

Our CEO, Dr. Tina Yu, had the honor of speaking at the event and connecting with the visionary leaders who are bringing world-class cancer care to New Jersey. This will be the first FIT proton therapy system in the state, underscoring Atlantic Health’s commitment to advancing care for patients and their families.

We are excited to see this partnership come to life and to support Atlantic Health in delivering precise, innovative cancer treatment to the community.

🌟 Here’s to a new era of cancer care in New Jersey!

Learn more: https://hubs.la/Q03NN1qP0

Leo Cancer Care The National Association for Proton Therapy

10/14/2025

We are immensely proud to partner with Atlantic Health as they break ground on New Jersey’s first MEVION S250-FIT Proton Therapy System. This milestone will bring advanced, precise cancer treatment closer to patients and families in the region. 🌟

10/09/2025

🚀 Mevion is at the Fall Career Fair at Massachusetts Maritime Academy!

📍 Clean Harbors Athletic Center
🗓️ Today, 3:00 – 6:00 PM

Come by our table to learn about career opportunities in advancing proton therapy and how you can be part of our mission to transform cancer care. 💡✨

Can’t make it? Explore our open roles anytime at 👉 https://hubs.la/Q03M-nvf0

We look forward to meeting you!

10/06/2025

💖 On October 4th, Team Mevion joined thousands of others in Boston for the Making Strides Against Breast Cancer walk.

We walked in honor of survivors, to support those currently fighting, and to remember loved ones we’ve lost. Together, we are helping fuel lifesaving research, patient support, and hope for a future without breast cancer. 🌸

Thank you to everyone who supported our team and this incredible cause. 💕

👉 You can still donate here: https://hubs.la/Q03Mhrbj0

10/03/2025

✨ With ASTRO 2025 now behind us, we at Mevion Medical Systems are proud to reflect on an inspiring week of innovation, collaboration, and momentum in advancing proton therapy.

Partnering with our brilliant colleagues at Leo Cancer Care, we continue to push the boundaries of cancer care with the Mevion S250-FIT™ - combining Mevion’s world-leading compact accelerator with Leo’s upright patient positioning and imaging technologies. Together, we’re making precision proton therapy more accessible than ever before.

From Stanford Medicine Cancer Center’s first installation to new commitments from BayCare, Atlantic Health System, Nebraska Medicine, and Loma Linda University Health, the energy and excitement at ASTRO highlighted the real progress being made.

We are grateful to celebrate these milestones with Leo Cancer Care and all of our clinical partners dedicated to expanding access to life-changing cancer care.

https://hubs.la/Q03M699X0

09/30/2025

Wrapping up our busiest and most successful ASTRO yet!

✨ FDA-cleared Mevion S250-FIT™ drew nonstop crowds at our buzzing booth.

✨ 200+ joined the Stanford Course on Modern Proton Therapy, touring their new S250-FIT and exploring the future of upright treatment.

✨ Our celebratory reception featured inspiring voices:
• Dr. Tina Yu on 20+ years of Mevion innovation
• Dr. James Slater from Loma Linda University Health on proton therapy’s legacy & future
• Jennifer Maggiore (The National Association for Proton Therapy) on expanding access worldwide

Together with partners like Leo Cancer Care we’re defining a new era - bringing proton therapy upright and within reach for more patients. Here’s to the future of cancer care!

09/29/2025

The Mevion crew is all smiles after an incredible first day in San Francisco at ASTRO 2025.

From reconnecting with colleagues to sharing the newly FDA-cleared MEVION S250-FIT Proton Therapy System, it’s been a fantastic start.

📍 Find us at Booth 1215 and come say hi, meet the team, and see how we’re making proton therapy more accessible than ever.

Excited for the next two days of innovation and connection at ! 💡

09/28/2025

✨ It’s show time!

Mevion Medical Systems is excited to welcome our colleagues and the entire community!

📍 Visit us at Booth 1215 to experience the recently FDA-cleared MEVION S250-FIT Proton Therapy System in action.

👋 Come meet our team and learn how Mevion is advancing proton therapy to make it more accessible than ever.

We look forward to connecting with you at ASTRO...see you soon!

09/27/2025

✨ At Mevion Medical Systems, our connections at ASTRO begin well before the meeting itself. Yesterday, we had the privilege of gathering for a Clinical Advisory Board meeting at Stanford Medicine Cancer Center, home to the world’s first MEVION S250-FIT™ proton therapy system.

The theme of the day was clear: proton therapy is on the rise, and Mevion is leading the way.

Our CEO, Dr. Tina Yu, reflected on a remarkable year that included:
• FDA clearance of the Mevion S250-FIT System
• New centers underway at Stanford, Nebraska Medicine, Loma Linda University, Baycare, and Atlantic Health

The enthusiasm from our board was evident. The meeting concluded with a behind-the-scenes tour of the fully installed S250-FIT™, where members experienced firsthand the power of the world’s smallest cyclotron.

We left energized by their excitement and inspired by the future ahead. This is only the beginning of a new era in patient care—and Mevion is proud to be leading it. 🚀

09/24/2025

🚀 A New Era in Cancer Care Begins

We’re proud to announce that Loma Linda University Health (LLUH), the pioneer of hospital-based proton therapy, has selected the MEVION S250-FIT Proton Therapy System™ to continue its legacy of innovation.

This milestone brings:
✨ Advanced HYPERSCAN® Pencil Beam Scanning for millimeter precision
✨ DirectArRC™ delivery for advanced treatment versatility
✨ Integrated diagnostic CT and upright patient positioning for greater comfort
✨ Future-ready capabilities, including FLASH* research support

As the world’s first hospital-based proton therapy center, LLUH has treated more than 24,000 patients since 1990. Today, with Mevion’s most compact and advanced technology, history meets the future — reaffirming a shared mission of compassionate, cutting-edge cancer care.

👉 Learn more: https://hubs.la/Q03KP-8W0

*For research use only and requires additional evaluation prior to use.

09/22/2025

✨ It’s almost show time at ASTRO 2025 in San Francisco! ✨

From September 27–October 1, we’re excited to connect with colleagues, partners, and friends from across the radiation oncology community as the meeting gets underway.

As if our FDA clearance of the MEVION S250-FIT™ Proton Therapy System (🎥 watch the announcement here https://hubs.la/Q03Knr_G0) wasn’t enough, we’ll have even more exciting news to share at ASTRO.

At Mevion, we are rising to meet every customer and every patient where they are. The S250-FIT delivers the highest-quality compact proton therapy system that not only enhances the patient experience but also provides greater access and efficiency for every health system and cancer center. You’ll see firsthand how our S250-FIT fits into a linac vault - making high-quality proton therapy possible for all.

🎯 Our mission is clear: to bring superior proton therapy to as many cancer patients as possible. Come be part of the new era of care at Booth #1215. We can’t wait to see you there.

Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.